- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04747379
Psychological Effect of Explicit Recall After Sedation (PEERS) (PEERS)
Psychological Effect of Explicit Recall After Sedation
Awareness, or explicit recall, under sedation is often intended and expected by anesthesiologists and is assumed that does not associate with any sequelae. Thus, awareness under sedation is a common event and is estimated to occur in around one-quarter of patients in our population. However, two recent registry studies suggested some patients with awareness under sedation have comparable psychological sequelae to those patients with awareness during general anesthesia. As such, we plan to conduct a a single center, prospective cohort study to evaluate the incidence, experience and psychological consequence of awareness under sedation.
In this study, we will prospectively include 2500 patients who will be scheduled to have major joint replacement surgery under regional anesthesia and sedation at University Hospital, London Health Sciences Center.
All participants will be assessed at four separate time points including:
- Enrollment/Surgical Preparatory Area (~ 2 hours before surgery)
- Post Anesthesia Care Unit (or up to 6 hours after surgery)
- Postoperative day one (in hospital)
- Postoperative 3 months (expected to be after discharge via telephone)
Study Overview
Status
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Jason Chui, MD
- Phone Number: 34435 519-685-8500
- Email: jason.chui@lhsc.on.ca
Study Contact Backup
- Name: LeeAnne Fochesato, MD
- Phone Number: 519-663-3384
- Email: LeeAnne.Fochesato@lhsc.on.ca
Study Locations
-
-
Ontario
-
London, Ontario, Canada, N6A 5A5
- Recruiting
- London Health Science Centre
-
Contact:
- Jason Chui, MBChB
-
Contact:
- LeeAnne Fochesato, MSc
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Adult patient (>18 years old)
- Scheduled to have orthopedic surgery or joint replacement therapy under sedation/regional anesthesia
- Patient is able to communicate in English
- ASA I-V
Exclusion Criteria:
- Unable to obtain informed consent
- Patient received General Anesthesia (GA) or conversion to GA during their surgical procedures
- Unable to conduct the survey such as language barrier, overt psychiatric disorder thought to interfere with the reliability of the interview (e.g. dementia etc)
- Patient who is expected to require mechanical ventilation at postoperative period (i.e. unable to perform surveys at Post-Anesthesia Care Unit (PACU) and postoperative day one)
- Unable to follow up via phone or attend a postoperative follow-up visit at postoperative 3 months
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Explicit recall
Time Frame: Up to 6 hours after surgery
|
Explicit recall will be assessed by Modified Brice Questionnaire
|
Up to 6 hours after surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Explicit Recall
Time Frame: Postoperative Day 1
|
Explicit recall will be assessed by Modified Brice Questionnaire The Michigan Awareness Classification is used to report the levels of sensation during awareness. 5 Levels of sensation are classified as auditory, tactile, pain, paralysis, or pain and paralysis. A designation of 'D' for distress is used for patient reports of fear, anxiety, suffocation, sense of doom, sense of impending death, or similar reports that indicated emotional distress during the explicit recall experience. |
Postoperative Day 1
|
Sensation During Awareness
Time Frame: Postoperative Day 1
|
The Michigan Awareness Classification - Michigan Score The Michigan Awareness Classification is used to report the levels of sensation during awareness. 5 Levels of sensation are classified as auditory, tactile, pain, paralysis, or pain and paralysis. A designation of 'D' for distress is used for patient reports of fear, anxiety, suffocation, sense of doom, sense of impending death, or similar reports that indicated emotional distress during the explicit recall experience. |
Postoperative Day 1
|
Details of recall experience
Time Frame: Postoperative Day 1
|
Light, smell, and other feelings The Michigan Awareness Classification is used to report the levels of sensation during awareness. 5 Levels of sensation are classified as auditory, tactile, pain, paralysis, or pain and paralysis. A designation of 'D' for distress is used for patient reports of fear, anxiety, suffocation, sense of doom, sense of impending death, or similar reports that indicated emotional distress during the explicit recall experience. |
Postoperative Day 1
|
Post Traumatic Stress Disorder
Time Frame: Postoperative 3 Months
|
PCL-S Questionnaire
|
Postoperative 3 Months
|
Depression
Time Frame: Postoperative 3 Months
|
PHQ-9 Questionnaire
|
Postoperative 3 Months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Jason Chui, MD, University of Western Ontario, Canada
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 114966
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Depression
-
ProgenaBiomeRecruitingDepression | Depression, Postpartum | Depression, Anxiety | Depression Moderate | Depression Severe | Clinical Depression | Depression in Remission | Depression, Endogenous | Depression ChronicUnited States
-
Washington University School of MedicineCompletedTreatment Resistant Depression | Late Life Depression | Geriatric Depression | Refractory Depression | Therapy-Resistant DepressionUnited States, Canada
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Vituity PsychiatryActive, not recruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
University of California, San FranciscoRecruitingDepression Moderate | Depression Mild | Depression, TeenUnited States
-
University GhentUniversiteit Antwerpen; Janssen-Cilag Ltd.RecruitingDepression Moderate | Depression Severe | Depression MildBelgium
-
Baylor College of MedicineUniversity of TexasRecruitingDepression | Depression Moderate | Depression Severe | Suicide and Self-harm | Depression in Adolescence | Depression MildUnited States
-
University of Cape TownNational Institute of Mental Health (NIMH)CompletedPostpartum Depression | Clinical Depression | Moderate DepressionSouth Africa
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; National Institute of Mental...CompletedMajor Depressive Disorder | Treatment Resistant Depression | Treatment-Refractory Depression | Late Life Depression | Geriatric DepressionUnited States, Canada
-
Northern Illinois UniversityUniversity Autonoma de Santo DomingoTerminatedDepression Moderate | Depression MildUnited States, Dominican Republic
-
Gerbera Therapeutics, Inc.Not yet recruitingPostpartum Depression | Depression, Postpartum | Postnatal Depression | Post-partum Depression | Post-Natal DepressionUnited States